Hunter C Smith

CIK 1636385 · Chief Financial Officer · last filed 2026-05-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.57M

Companies

4

Total Filings

73

Lifetime Open-Market Net

-$12.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RYTM Chief Financial Officer 119,611 $88.38 $10.57M -$12.80M 45 2026-05-20
Spyre Therapeutics, Inc. (AGLE) Delisted Director $12.01 $0 3 2023-06-30
GENESEE & WYOMING INC (GWR) Delisted Director 0 $0 22 2019-12-30
GENESEE & WYOMING INC (GWRU) Delisted Director 1,226 $0 3 2015-07-02

Recent Filings · Page 2 of 8

73 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-19 RYTM Mixed +4,385 -$126.7K EDGAR
2025-02-14 RYTM Sell (S) −751 -$42.3K EDGAR
2025-02-11 RYTM Mixed +5,109 -$74.5K EDGAR
2025-02-04 RYTM Mixed +3,247 -$99.7K EDGAR
2024-03-19 RYTM Sell (S) −15,515 -$608.5K EDGAR
2024-02-21 RYTM Grant (A) +33,750 $0 EDGAR
2024-02-13 RYTM Mixed +4,489 -$97.4K EDGAR
2024-02-05 RYTM Mixed +3,309 -$72.8K EDGAR
2024-01-03 RYTM Exer (M) +10,500 $72.2K EDGAR
2023-12-07 RYTM Mixed -$860.4K EDGAR
Showing 1120 of 73
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.